| NMR Experiment |
|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
|---|
| 1 | 2D 1H-1H TOCSY | 0.58 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: alpha-Me-Leu13, Aib17, alpha-Me-Lys20, 20 mM [U-2H] sodium acetate, 0.13 mM 4,4-dimethyl-4-silapentane-1-ammonium trifluoroacetate (DSA) | 90% H2O/10% D2O | 29 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
| 2 | 2D 1H-1H COSY | 0.58 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: alpha-Me-Leu13, Aib17, alpha-Me-Lys20, 20 mM [U-2H] sodium acetate, 0.13 mM 4,4-dimethyl-4-silapentane-1-ammonium trifluoroacetate (DSA) | 90% H2O/10% D2O | 29 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
| 3 | 2D DQF-COSY | 0.58 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: alpha-Me-Leu13, Aib17, alpha-Me-Lys20, 20 mM [U-2H] sodium acetate, 0.13 mM 4,4-dimethyl-4-silapentane-1-ammonium trifluoroacetate (DSA) | 90% H2O/10% D2O | 29 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
| 4 | 2D 1H-1H NOESY | 0.58 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: alpha-Me-Leu13, Aib17, alpha-Me-Lys20, 20 mM [U-2H] sodium acetate, 0.13 mM 4,4-dimethyl-4-silapentane-1-ammonium trifluoroacetate (DSA) | 90% H2O/10% D2O | 29 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
